相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
Robert Coleman et al.
LANCET ONCOLOGY (2020)
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer
Francesco Pantano et al.
SCIENTIFIC REPORTS (2020)
A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells
Yanshu Li et al.
ONCOGENE (2019)
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Michael Gnant et al.
LANCET ONCOLOGY (2019)
Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis
Kerstin Tiedemann et al.
TRANSLATIONAL ONCOLOGY (2019)
Prediction of Bone Metastasis in Breast Cancer Based on Minimal Driver Gene Set in Gene Dependency Network
Jia-Nuo Li et al.
GENES (2019)
Correction: MicroRNA-34a expression levels in serum and intratumoral tissue can predict bone metastasis in patients with hepatocellular carcinoma
Zuo-Lin Xiang et al.
Oncotarget (2019)
Circulating Tumor Cells: Overview and Opportunities in Cytology
Kaitlin E. Sundling et al.
ADVANCES IN ANATOMIC PATHOLOGY (2019)
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours
Francesca M. Rizzo et al.
BRITISH JOURNAL OF CANCER (2019)
Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer
Jules A. Westbrook et al.
JOURNAL OF PATHOLOGY (2019)
Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis
C. Probert et al.
ONCOGENE (2019)
A gene expression signature-based nomogram model in prediction of breast cancer bone metastases
Chenglong Zhao et al.
CANCER MEDICINE (2019)
The key role of extracellular vesicles in the metastatic process
Hongyun Zhao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
Sadakatsu Ikeda et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
Janet Brown et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
Kyoko Hashimoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Circulating tumor cells mirror bone metastatic phenotype in prostate cancer
Andreas Josefsson et al.
Oncotarget (2018)
Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial
Janet Brown et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes
Martine Croset et al.
CANCER RESEARCH (2018)
Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer
Tstutomu Kawaguchi et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Circulating tumor DNA as prognostic markers for late stage NSCLC with bone metastasis
Jiguang Jia et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2018)
MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2
Melissa Colden et al.
CELL DEATH & DISEASE (2017)
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions
Marco Fioramonti et al.
ONCOTARGET (2017)
The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation
Ashley Sutherland et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
The Role of Prolactin in Bone Metastasis and Breast Cancer Cell-Mediated Osteoclast Differentiation
Ashley Sutherland et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
Jules A. Westbrook et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
IL-1 drives breast cancer growth and bone metastasis in vivo
Ingunn Holen et al.
ONCOTARGET (2016)
Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study
Nicolas Pecuchet et al.
PLOS MEDICINE (2016)
CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment
Jules A. Westbrook et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease
Hanna Taipaleenmaeki et al.
CANCER RESEARCH (2015)
ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway
Xiao-Qing Li et al.
CANCER RESEARCH (2015)
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
R. Coleman et al.
LANCET (2015)
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12
M. Gnant et al.
ANNALS OF ONCOLOGY (2015)
Epithelial-Mesenchymal Transitioned Tumor Cells Capture for Detecting Tumor Progression
Arun Satelli et al.
CLINICAL CANCER RESEARCH (2015)
Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting
Carmel Jacobs et al.
JOURNAL OF BONE ONCOLOGY (2015)
Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort
K. Tikk et al.
ANNALS OF ONCOLOGY (2014)
Circulating Tumor Cells are Associated with Bone Metastasis of Lung Cancer
Min Cheng et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis
Klaus Jung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Detection of circulating tumor DNA in early and late stage human malignancies
Chetan Bettegowda et al.
CANCER RESEARCH (2014)
Different molecular profiles are associated with breast cancer cell homing compared with colonisation of bone: evidence using a novel bone-seeking cell line
Faith Nutter et al.
ENDOCRINE-RELATED CANCER (2014)
miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization
Karmele Valencia et al.
MOLECULAR ONCOLOGY (2014)
被撤回的出版物: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2 (Retracted article. See vol. 582, pg. 134, 2020)
Jing Y. Krzeszinski et al.
NATURE (2014)
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
R. Coleman et al.
ANNALS OF ONCOLOGY (2013)
Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
Takehiko Yokobori et al.
CANCER RESEARCH (2013)
Prospective Study of Urinary and Serum Cross-Linked N-Telopeptide of Type I Collagen (NTx) for Diagnosis of Bone Metastasis in Patients With Lung Cancer
Motohiro Tamiya et al.
CLINICAL LUNG CANCER (2013)
Disseminated tumor cells and their prognostic significance in nonmetastatic prostate cancer patients
Wolfgang Lilleby et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
Min Yu et al.
SCIENCE (2013)
Gene expression markers in circulating tumor cells may predict bone metastasis and response to hormonal treatment in breast cancer
Haiying Wang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Vitamin D, but not bone turnover markers, predict relapse in women with early breast cancer: an AZURE translational study.
R. E. Coleman et al.
CANCER RESEARCH (2012)
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
Alexander H. G. Paterson et al.
LANCET ONCOLOGY (2012)
MicroRNA control of bone formation and homeostasis
Jane B. Lian et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Serum tartrate-resistant acid phosphatase 5b (TRACP5b) activity as a biomarker for bone metastasis in non-small cell lung cancer patients
Nai-Shun Yao et al.
CLINICA CHIMICA ACTA (2011)
Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse-A European Pooled Analysis
Wolfgang Janni et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic Significance of Bone Markers in Patients With Lung Cancer Metastatic to the Skeleton: A Review of Published Data
Giannis Mountzios et al.
CLINICAL LUNG CANCER (2011)
Expression Pattern of Receptor Activator of NFκB (RANK) in a Series of Primary Solid Tumors and Related Bone Metastases
Daniele Santini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Elevated Bone Turnover Predicts for Bone Metastasis in Postmenopausal Breast Cancer: Results of NCIC CTG MA.14
Allan Lipton et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Receptor Activator of NF-κB (RANK) Expression in Primary Tumors Associates with Bone Metastasis Occurrence in Breast Cancer Patients
Daniele Santini et al.
PLOS ONE (2011)
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer
U. De Giorgi et al.
ANNALS OF ONCOLOGY (2010)
Clinical and imaging correlations of bone turnover markers in prostate cancer patients with bone only metastases
Athanasios G. Zafeirakis et al.
NUCLEAR MEDICINE COMMUNICATIONS (2010)
Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
Todd M. Morgan et al.
CLINICAL CANCER RESEARCH (2009)
Circulating Prostate Tumor Cells Detected by Reverse Transcription-PCR in Men with Localized or Castration-Refractory Prostate Cancer: Concordance with CellSearch Assay and Association with Bone Metastases and with Survival
Pauliina Helo et al.
CLINICAL CHEMISTRY (2009)
Disseminated tumor cells of breast cancer patients: A strong prognostic factor for distant and local relapse
Francois-Clement Bidard et al.
CLINICAL CANCER RESEARCH (2008)
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance
Mark B. Meads et al.
CLINICAL CANCER RESEARCH (2008)
The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites
Y. Shiozawa et al.
LEUKEMIA (2008)
Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells
F. -C. Bidard et al.
ANNALS OF ONCOLOGY (2008)
Serum bone turnover markers (PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: A longitudinal approach
N. Koopmans et al.
JOURNAL OF UROLOGY (2007)
Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma
Azizbek Ramankulov et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells
S. L. Miller et al.
ONCOGENE (2007)
Plasma osteopontin in comparison with bone markers as indicator of bone metastasis and survival outcome in patients with prostate cancer
Azizbek Ramankulov et al.
PROSTATE (2007)
Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells
A. Bellahcene et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Clinical use of markers of bone turnover in metastatic bone disease
MJ Seibel
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer
E Salminen et al.
ACTA ONCOLOGICA (2005)
A pooled analysis of bone marrow micrometastasis in breast cancer
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid
RE Coleman et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors
JE Brown et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread:: Diagnostic and prognostic implications
K Jung et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer
NV Lyubimova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2004)
Dissemination and growth of cancer cells in metastatic sites
AF Chambers et al.
NATURE REVIEWS CANCER (2002)
The serum level of the amino-terminal propeptide of type I procollagen is a sensitive marker for prostate cancer metastasis to bone
M Koizumi et al.
BJU INTERNATIONAL (2001)
分享论文
